GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,420 | +190.3% | 40,844 | +119.3% | 0.00% | – |
| Q3 2022 | $6,000 | -85.4% | 18,628 | -68.8% | 0.00% | – |
| Q2 2022 | $41,000 | +105.0% | 59,625 | +373.7% | 0.00% | – |
| Q1 2022 | $20,000 | -74.4% | 12,588 | -55.2% | 0.00% | – |
| Q3 2021 | $78,000 | -51.6% | 28,114 | -46.9% | 0.00% | – |
| Q2 2021 | $161,000 | +215.7% | 52,937 | +257.7% | 0.00% | – |
| Q1 2021 | $51,000 | -41.4% | 14,800 | +15.6% | 0.00% | – |
| Q4 2018 | $87,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|